Exclusive Market Insights
YMAX Pays an 8.7% Yield. Its Ten-Year Return Was Lower Than That
YMAX turns ASX blue-chip upside into income, but the yield comes with a trade-off.
The Investor Standard – Your Investing Edge
Receive curated weekly stock picks, top-performing equities, and actionable investment ideas to maximise your portfolio potential.
All the latest Investor Standard news and insights delivered straight to your inbox.
Investor Insights, Delivered
Unlock expert insights, stock recommendations, and market analysis – all in one place. Get the latest market news and stock picks instantly.
Further Analysis & Commentary
Retail Rush at the Top? What the ASX’s Hot-Stock Frenzy Means
Retail participation on the ASX jumped through the September quarter as the index broke above 9000, with online retail investors…
Cynata Therapeutics (ASX: CYP): Speculative Investment Analysis
Business Overview Cynata Therapeutics is a clinical-stage biotechnology company developing cell therapies based on Cymerus, its induced pluripotent stem cell…
Gold & Silver Surge Playbook: Who Wins and What to Watch
Gold's explosive rally past US$4,150 an ounce and silver's surge beyond US$52.50 an ounce have transformed global sentiment toward precious…
Big Four Banks and the Next Wave of Digital Lending: Opportunities and Risks
In 2025, Australia’s banking landscape is at a digital crossroads. The country’s Big Four banks—Commonwealth Bank, Westpac, National Australia Bank,…

Monthly Investor Memo
Delivered Monthly - 2026